Эффективность низкоэнергетического

Эффективность низкоэнергетического светового облучения у больных с экссудативной формой возрастной макулярной дегенерации после анти-VEGF терапии
Резюме
Изучена эффективность низкоэнергетического светового облучения у пациентов с экссудативной формой возрастной макулярной дегенерации после анти – VEGF терапии. Основную группу составили 62 пациента (69 глаз), которым проводили два курса низкоэнергетического светового облучения с интервалом в 6 месяцев после анти – VEGF терапии. Контрольная группа 41 пациент (44 глаза) до наблюдения проходила только анти – VEGF терапию. Общий срок наблюдения составил 1 год. В результате исследования обнаружено стабилизация остроты зрения, уменьшение толщины сетчатки в fovea, задержка развития патологических изменений микроструктуры макулы у пациентов основной группы. В контрольной группе было отмечено прогрессирование заболевания. Целесообразно проведение повторных курсов облучения у пациентов с экссудативной формой возрастной макулярной дегенерации после анти – VEGF терапии через 3-6 месяцев. Использование низкоэнергетического светового облучения позволяет уменьшить количество последующих интравитреальных инъекций анти-VEGF препаратов и увеличить сроки между инъекциями.

Результаты (английский) 1:

The effectiveness of low-energy light irradiation in patients with exudative form of age-related macular degeneration after anti-VEGF therapySummaryStudied the effectiveness of low-energy light irradiation in patients with exudative form of age-related macular degeneration after anti-VEGF therapy. The main group included 62 patients (the 69 eyes), who received two courses of low-energy light radiation within 6 months after the anti-VEGF therapy. A control group of 41 patients (44 eyes) to the monitoring took place only anti-VEGF therapy. The total period of observation was 1 year. The study found the stabilization of Visual acuity, the decrease in the thickness of the retina, the fovea of the delay in the development of pathological changes of the microstructure of the macula in the core group. In the control group showed the progression of the disease. Appropriate re courses irradiation in patients with exudative form of age-related macular degeneration after anti-VEGF therapy through 3-6 months. The use of low-energy light exposure can reduce the number of subsequent intravitreal′nyh injection of anti-VEGF medications and increase the time between injections.

Результаты (английский) 2:

The effectiveness of low-energy light irradiation in patients with exudative form of age-related macular degeneration after anti-VEGF therapy
Summary
The efficiency of low-energy light irradiation in patients with exudative form of age-related macular degeneration after anti - VEGF therapy. A study group comprised 62 patients (69 eyes) who underwent two courses of low-energy light irradiation at an interval of 6 months after anti - VEGF therapy. A control group of 41 patients (44 eyes) to the observation took place only anti - VEGF therapy. The total follow-up of 1 year. The study found the stabilization of visual acuity reduction in retinal thickness in fovea, delay the development of pathological changes in the microstructure of the macula in patients of the main group. In the control group it was noted disease progression. It is advisable to repeat courses of irradiation in patients with exudative form of age-related macular degeneration after anti - VEGF therapy in 3-6 months. Use of low-energy light radiation can reduce the amount of subsequent intravitreal injections of anti-VEGF agents and increase periods between injections.

Результаты (английский) 3:

The rays will penetrate light exposure in patients with экссудативнои form age макулярнои dryland degeneration after anti-VEGF therapy
Summary
We examined the efficiency light exposure in patients with экссудативнои form age макулярнои dryland degeneration after anti-VEGF therapy. The core group amounted to 62 patients (69 eyes).Which conducted two courses rays will penetrate light exposure with the interval of 6 months after anti-VEGF therapy. Control group 41 patients (44 eyes) before monitoring was held only anti-VEGF therapy.The general term monitoring was $1 per year. As a result of the study found stabilization of poverty alleviation, thickness reduction in retina fоveа,